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The mechanism mediating the activation of acetylcoenzyme A carboxylase-a gene transcription by the
liver X receptor agonist T0-901317
Saswata Talukdar and F. Bradley Hillgartner1
Department of Biochemistry and Molecular Pharmacology, School of Medicine, West Virginia University,
Morgantown, WV 26506

Abstract In birds and mammals, agonists of the liver X receptor (LXR) increase the expression of enzymes that make
up the fatty acid synthesis pathway. Here, we investigate the
mechanism by which the synthetic LXR agonist, T0-901317,
increases the transcription of the acetyl-coenzyme A carboxylase-a (ACCa) gene in chick embryo hepatocyte cultures.
Transfection analyses demonstrate that activation of ACCa
transcription by T0-901317 is mediated by a cis-acting regulatory unit (2101 to 271 bp) that is composed of a liver X
receptor response element (LXRE) and a sterol-regulatory
element (SRE). The SRE enhances the ability of the LXRE to
activate ACCa transcription in the presence of T0-901317.
Treating hepatocytes with T0-901317 increases the concentration of mature sterol-regulatory element binding protein1 (SREBP-1) in the nucleus and the acetylation of histone
H3 and histone H4 at the ACCa LXR response unit. These
results indicate that T0-901317 increases hepatic ACCa
transcription by directly activating LXR&retinoid X receptor (RXR) heterodimers and by increasing the activity of
an accessory transcription factor (SREBP-1) that enhances
ligand induced-LXR&RXR activity.—Talukdar, S., and F. B.
Hillgartner. The mechanism mediating the activation of
acetyl-coenzyme A carboxylase-a gene transcription by the
liver X receptor agonist T0-901317. J. Lipid Res. 2006. 47:
2451–2461.
Supplementary key words fatty acid synthesis & sterol-regulatory
element binding protein & thyroid hormone & chicken & histone
acetylation

The first committed step of the fatty acid synthesis
pathway is the ATP-dependent carboxylation of acetyl-CoA
to form malonyl-CoA. This reaction, catalyzed by acetylcoenzyme A carboxylase-a (ACCa), constitutes a key
control point in the synthesis of long-chain fatty acids
from carbohydrate (1, 2). Malonyl-CoA serves as a donor
of C2 units for the synthesis of palmitate catalyzed by fatty
acid synthase. Malonyl-CoA is also a substrate of specific

elongases involved in the chain elongation of fatty acids to
very-long-chain fatty acids (3). The essential role of ACCa
in lipid biosynthesis has been confirmed by studies demonstrating that knockout of the ACCa gene disrupts embryonic development before day 7.5 (4).
In lipogenic tissues of birds and mammals, transcription of the ACCa gene is regulated by nutritional and hormonal factors. For example, ACCa transcription is low in
livers of starved chicks, and feeding a high-carbohydrate,
low-fat diet stimulates an 11-fold increase in ACCa transcription (5). Diet-induced changes in ACCa transcription
are mimicked in primary cultures of chick embryo hepatocytes by manipulating the concentrations of hormones
and nutrients in the culture medium (6). Incubating chick
embryo hepatocytes with the active form of the thyroid
hormone 3,59,3-triiodothyronine (T3) stimulates a 5- to
7-fold increase in ACCa transcription. The mechanism by
which T3 increases ACCa transcription involves multiple processes. First, T3 interacts with the nuclear 3,59,
3-triiodothyronine receptor (TR) bound to a 3,59,3triiodothyronine response element (T3RE) on the more
downstream promoter (promoter 2) of the ACCa gene
(7). This T3RE (2101 to 286 bp) is composed of two hexameric half-sites arranged as direct repeats with 4 bp separating the half-sites (DR-4 element). Second, T3 treatment
increases the binding of TR&retinoid X receptor (RXR)
heterodimers to the ACCa T3RE. The mechanism for this
effect has not been defined. Third, T3 treatment increases
the binding of sterol-regulatory element binding protein-1
(SREBP-1) to a sterol-regulatory element (SRE) (280 to
271 bp) located immediately downstream of the ACCa
T3RE (8). SREBP-1 directly interacts with TR&RXR heterodimers and enhances the ability of this complex to
activate ACCa transcription in the presence of T3 (9).
In our studies analyzing the regulation of ACCa transcription by T3, we observed that the ACCa T3RE not only
bound protein complexes containing TR&RXR hetero-
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dimers but also bound protein complexes containing liver
X receptor (LXR)&RXR heterodimers (7). LXRs are nuclear hormone receptors that are bound and activated by
naturally occurring oxysterols (10, 11). Two isoforms of
LXR, designated LXRa and LXRb, have been identified
in birds and mammals. LXRb is expressed in a wide variety
of tissues, whereas LXRa is selectively expressed in liver,
adipose tissue, intestine, and macrophages (12, 13). LXRs
play a key role in regulating cholesterol excretion by mediating the stimulatory effects of oxysterols on the transcription of genes involved in reverse cholesterol transport
and bile acid synthesis. For example, naturally occurring
oxysterols and synthetic, nonsteroidal LXR agonists
activate the transcription of a battery of genes involved
in cholesterol efflux (ABCA1, ABCG1, ABCG5, and
ABCG8), cholesterol clearance (cholesteryl ester transfer
protein and apolipoprotein E), and cholesterol catabolism
(cholesterol 7a-hydroxylase) (14–16). For each of these
genes, regulation of transcription by LXR agonists is conferred by a liver X receptor response element (LXRE) that
binds LXR&RXR heterodimers. Because oxysterols are
produced in proportion to cellular cholesterol content,
LXRs have been proposed to function as sensors in a feedforward pathway that stimulates reverse cholesterol transport and cholesterol excretion in response to high
cholesterol levels in the diet. Consistent with this proposal,
mice lacking the LXRa and/or LXRb gene exhibit diminished cholesterol excretion and increased cholesterol
levels in the blood and liver when fed a high-cholesterol
diet (17, 18).
The ability of LXR agonists to activate genes involved
in cholesterol excretion has led to an evaluation of the
atheroprotective properties of these compounds in murine models of atherosclerosis. Oral administration of the
synthetic LXR ligand/agonist, T0-901317, to mice lacking
the LDL receptor or apolipoprotein E causes an increase
in blood HDL levels and reverses the formation of atherosclerotic lesions in the aorta (19, 20). LXR agonists also
improve insulin sensitivity in murine models of type 2 diabetes (21, 22). These exciting findings are tempered by
the observation that treatment with T0-901317 also causes
hypertriglyceridemia and the development of a fatty liver
in rodents and chickens (23–26). These undesired effects
of T0-901317 are caused by alterations in the expression of enzymes that make up the fatty acid synthesis
pathway. For example, T0-901317 treatment increases
the hepatic expression of the mRNAs encoding ACCa,
FAS, ATP-citrate lyase (ATP-CL), and stearoyl-coenzyme A
desaturase-1 (SCD1) (25–27). The aim of this study was to
determine the mechanism by which T0-901317 regulates
the expression of ACCa in avian liver. We show that
T0-901317 acts directly on the liver to increase the expression of ACCa and that the extent of this effect is
modulated by the presence of insulin and T3. We further
show that T0-901317 increases ACCa transcription by
activating LXR&RXR heterodimers bound to the ACCa
LXRE/T3RE and that SREBP-1 interacts with LXR&RXR
to enhance the stimulatory effects of T0-901317 on
ACCa transcription.
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EXPERIMENTAL PROCEDURES
Cell culture and analytical assays
Hepatocytes were isolated from livers of 19 day old chick
embryos as described previously (28). Cells were incubated
in serum-free Waymouth’s medium MD752/1 containing penicillin (60 mg/ml) and streptomycin (100 mg/ml) on untreated
Petri dishes at 408C in a humidified atmosphere of 5% CO2 and
95% air. Hormone and other additions were as described in the
figure legends. The triacylglycerol concentration of the culture
medium was measured using an enzymatic kit (Sigma).

Isolation of RNA and quantitation of mRNA levels
Medium was removed and RNA was extracted from hepatocytes by the guanidinium thiocyanate/phenol/chloroform
method (29). Total RNA (15 mg) was separated by size on 0.9%
agarose, 0.7 M formaldehyde gels and then transferred to a
Nytran membrane (Schleicher and Schuell) using a vacuum
blotting apparatus (Pharmacia Biotechnology). The RNA was
cross-linked to the membrane by ultraviolet light and baked at
808C for 30–60 min. RNA blots were hybridized with 32P-labeled
DNA probes labeled by random priming (30). Hybridization and
washes were as described (31). Membranes were subjected to
storage phosphor autoradiography. Hybridization signals were
quantified using ImageQuant software (Molecular Dynamics).
cDNAs for chicken ACCa (5), FAS (32), SCD1 (33), SREBP-1
(34), ATP-CL (35), ABCA1 (25), LXRa (36), and malic enzyme
(37) have been described.

Plasmids
Reporter plasmids are named by designating the 59 and 39
ends of the ACCa DNA fragment relative to the transcription
start site of promoter 2. A series of 59 deletions and 39 deletions
of ACCa promoter 2 in the context of p[ACC22054/1274]
chloramphenicol acetyltransferase (CAT) have been described
(7). An ACCa promoter construct containing a mutation of the
SRE between 279 and 272 bp in the context of p[ACC2108/
1274]CAT has been described (9). p[ACC2108/266]TKCAT,
p[ACC284/266]TKCAT, and pTKCAT constructs, containing
mutations in the 2108 to 266 bp ACCa fragment, have been
described (9).

Transient transfection
Chick embryo hepatocytes were transfected as described by
Zhang, Yin, and Hillgartner (7). Briefly, cells were isolated and
incubated on 60 mm Petri dishes. At 6 h of incubation, the
medium was replaced with one containing 10 mg of lipofectin
(Invitrogen), 1.5 mg of p[ACC22054/1274]CAT or an equimolar amount of another reporter plasmid, and pBluescript KS(1)
to bring the total amount of transfected DNA to 1.5 mg per
plate. At 18 h of incubation, the transfection medium was replaced with fresh medium with or without T0-901317 (6 mM).
At 66 h of incubation, chick embryo hepatocytes were harvested
and cell extracts were prepared as described (38). CAT activity
(39) and protein (40) were assayed by the indicated methods.

Western blot analysis
Nuclear extracts were prepared from chick embryo hepatocytes as described (9). The proteins of the nuclear extract were
subjected to electrophoresis on 10% SDS-polyacrylamide gels
and then transferred to polyvinylidene difluoride membranes
(Millipore) using an electroblotting apparatus (Bio-Rad Laboratories, Hercules, CA). Immunoblot analysis was carried out using

a mouse monoclonal antibody against SREBP-1 (IgG-2A4; American Type Culture Collection, Manassas, VA). Antibody/protein
complexes on blots were detected using enhanced chemiluminescence (Amersham Biosciences). Chemiluminescence on the
blots was visualized using a FluorChem 8000 imager (Alpha
Innotech Corp.), and signals for the mature form of SREBP-1
were quantified using FluorChem V200 software.

Histone acetylation
The extent of histone acetylation on ACCa promoter 2 was
measured using a chromatin immunoprecipitation (ChIP) assay.
The procedure for this assay was as described by Yin et al. (41).
ChIP assays were carried out with antibodies against acetylhistone H3 (06-599) and acetyl-histone H4 (06-866; Upstate Biotechnology). Precipitated DNA was analyzed by PCR using Taq
DNA polymerase (New England Biolabs) and primers specific
for the ACCa and SCD1 promoters. The cycling parameters were
as follows: 1 cycle of 958C for 4 min; 30 cycles of 958C for 1 min,
618C for 1 min, and 728C for 1 min; and 1 cycle of 728C for
10 min. The forward primer of the ACCa gene was 59-TCCCCTCCGTCAGCAGCCAATGGG-39; the reverse primer was 59ATCCCCGGTCCCGCCCTCGGCTCC-39. The forward primer of
the SCD1 gene was 59-AGCGAACAGCAGATTGCGGCAG-39; the
reverse primer was 59-TCTCGGCGTGCCAGAAGGGAGGT-39.
Amplified products were subjected to electrophoresis on 2%
agarose gels and visualized by ethidium bromide staining.

Statistical methods
Data were subjected to ANOVA, and statistical comparisons
were made with Dunnett’s test or Student’s t-test. Statistical significance was defined as P , 0.05.

RESULTS
LXR activation increases the expression of ACCa in
primary cultures of chick embryo hepatocytes
Oral administration of T0-901317 to chickens and rats
causes a 2- to 3-fold increase in hepatic ACCa mRNA levels
(25, 26). To investigate whether this phenomenon was
attributable to a direct effect of T0-901317 in the liver, we
determined whether T0-901317 regulated the expression
of ACCa in primary cultures of chick embryo hepatocytes.
Incubating hepatocytes with T0-901317 in the absence of
other hormones for 24 h caused a 2.4-fold increase in the
abundance of ACCa mRNA (Fig. 1). Treatment with the
RXR agonist 9-cis retinoic acid had no effect on ACCa
mRNA abundance in the absence or presence of T0901317. Thus, LXR agonists but not RXR agonists regulate
ACCa expression in hepatocyte cultures.
In chick embryo hepatocytes, insulin has no effect by
itself but amplifies the increase in ACCa transcription
caused by T3 (6). This observation prompted us to investigate whether insulin modifies the effects of T0-901317 on
ACCa expression. Incubating hepatocytes with T0-901317
stimulated a greater increase in ACCa mRNA abundance
in the presence of insulin (3.5-fold) than in the absence of
insulin (2.4-fold) (Fig. 1). Thus, as observed for T3 regulation of ACCa, insulin enhances the stimulatory effects of
T0-901317 on ACCa expression.

In previous work, we showed that both TR and LXR
bind the ACCa T3RE as heterodimers with RXR (7). This
observation raised the possibility that a common cis-acting
regulatory sequence is involved in mediating the effects
of T0-901317 and T3 on ACCa transcription. As a first step
in investigating this possibility, we determined the effects
of T0-901317 on the expression of ACCa in the presence
of T3. Incubating hepatocytes with T3 and insulin caused
a 4.6-fold increase in the abundance ACCa mRNA abundance (Fig. 1). Addition of T0-901317 in the presence of
T3 and insulin caused a further increase in ACCa mRNA
abundance, although the magnitude of this effect (39%)
was substantially smaller than the effect of T0-901317 on
ACCa expression in the presence of insulin alone (350%).
Addition of T0-901317 in the presence of T3, insulin, and
9-cis retinoic acid had no effect on ACCa mRNA abundance. The nonadditive effects of T0-901317 and T3 on
ACCa mRNA abundance support the proposal that a
common cis-acting sequence(s) mediates the actions of
T0-901317 and T3 on ACCa transcription.
We also investigated the effects of T0-901317 on the
expression of other lipogenic enzymes. In hepatocytes
incubated in the absence and presence of insulin, addition
of T0-901317 to the culture medium increased the
abundance of mRNAs encoding FAS, SCD1, and ATP-CL
(Fig. 1). T0-901317-induced expression of FAS, SCD1, and
ATP-CL was higher in the presence of insulin than in the
absence of insulin. In hepatocytes incubated with T3 and
insulin, addition of T0-901317 caused a small increase
(32%) in the abundance of FAS mRNA but had no effect
on the abundance of SCD1 mRNA or ATP-CL mRNA.
Incubating hepatocytes with 9-cis retinoic acid in the
absence or presence of T0-901317 had no effect on FAS,
SCD1, and ATP-CL mRNA levels. Thus, regulation of the
expression of FAS, SCD1, and ATP-CL by agonists of LXR
and RXR is similar to that of ACCa.
In contrast to ACCa, FAS, SCD1, and ATP-CL, the ability
of T0-901317 to increase the expression of malic enzyme
was substantially lower than that of T3. Treatment with T0901317 and insulin caused a 2.9-fold increase in malic
enzyme mRNA abundance, whereas treatment with T3
and insulin caused a 35-fold increase in malic enzyme
mRNA abundance (Fig. 1). These observations are consistent with previous work demonstrating that the major
T3RE mediating T3 regulation of malic enzyme transcription lacks the ability to bind LXR&RXR heterodimers (7).
To determine whether the T0-901317-induced increase
in lipogenic enzyme expression was associated with an
increase in triacylglycerol production, the triacylglycerol
concentration in the culture medium was monitored
in hepatocytes treated with or without T0-901317. The
triacylglycerol concentration of the culture medium
increased progressively during a 48 h incubation period
(Fig. 2). The extent of the increase in triacylglycerol
concentration was higher in cells treated with T0-901317
relative to cells not receiving T0-901317. An increase in
hepatic lipogenic enzyme expression and triacylglycerol
secretion likely contributes to the hypertriglyceridemia
observed in animals treated with T0-901317 (23, 24, 26).
Regulation of acetyl-CoA carboxylase by LXR
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Fig. 1. The liver X receptor (LXR) agonist T0-901317 increases the expression of acetyl-coenzyme A
carboxylase-a (ACCa) and other lipogenic enzymes in primary cultures of chick embryo hepatocytes.
Hepatocytes were isolated as described in Experimental Procedures and incubated in serum-free
Waymouth’s medium. At 18 h of incubation, the medium was changed to one of the same composition
supplemented with or without T0-901317 (6 mM) in the absence or presence of insulin (50 nM), insulin and
9-cis retinoic acid (9-Cis RA; 100 nM), insulin and 3,59,3-triiodothyronine (T3; 1.5 mM), or insulin, T3, and 9cis retinoic acid. After 28 h of treatment, total RNA was isolated and the abundance of mRNA encoding
ACCa, FAS, stearoyl-coenzyme A desaturase-1 (SCD1), ATP-citrate lyase (ATP-CL), malic enzyme (ME),
ABCA1, and LXRa was measured by Northern analysis. Levels of mRNA in cells treated without T0-901317,
9-cis retinoic acid, insulin, and T3 were set at 1, and the other values were adjusted proportionally. Values are
means 6 SEM of four experiments. Hybridization signals from a representative experiment are shown for
each mRNA. Ribosomal subunits (27S and 18S) stained with ethidium bromide are shown as controls for
RNA loading. a Mean is significantly (P , 0.05) different from that of cells treated without T0-901317, 9-cis
retinoic acid, insulin, and T3; b mean is significantly (P , 0.05) different from that of cells treated with
insulin; c mean is significantly (P , 0.05) different from that of cells treated with insulin and T3.

Identification of a LXR response unit that mediates the
effects of T0-901317 on ACCa transcription
Previous studies have shown that T3 regulation of ACCa
transcription is mediated by a 23 bp region (2101 to
271 bp) in promoter 2 of the ACCa gene (7). This region
2454
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contains a DR-4 element (2101 to 286 bp) that binds
heterodimers composed of TR&RXR and LXR&RXR and a
SRE (282 to 271 bp) that binds SREBP-1. To determine
the role of these sequences and other sequences in the
ACCa gene in mediating the stimulatory effects of T0-

ment containing the ACCa SRE alone (284 to 266 bp) was
appended to the TK promoter, T0-901317 treatment had
no effect on promoter activity. These data demonstrate that
the ACCa SRE can function alone to enhance T0-901317
regulation conferred by the ACCa LXRE. Thus, a region
of the ACCa gene containing a LXRE and a SRE is responsible for mediating the effects of T0-901317 on ACCa
promoter 2 activity. We refer to this region as the ACCa liver
X receptor response unit (LXRU).

Fig. 2. Effect of T0-901317 on the accumulation of triacylglycerols
in the culture medium of chick embryo hepatocytes. Hepatocytes were plated on 90 mm Petri dishes (1 3 107 cells/dish) in
Waymouth’s medium containing insulin. At 18 h of incubation, the
medium was changed to one of the same composition supplemented with or without T0-901317. After 0, 24, 36, and 48 h of
incubation with T0-901317, the concentration of triacylglycerol in
the culture medium was measured using a spectrophotometric
assay. Data are means 6 SEM of three experiments. * Mean is
significantly (P , 0.05) different from that of cells incubated with
insulin for the same time period.

901317 on ACCa transcription, transient transfection experiments were performed using reporter constructs containing portions of ACCa promoter 2 linked to the CAT
gene. In chick embryo hepatocytes transfected with a reporter construct containing 2,054 bp of 59-flanking DNA,
T0-901317 caused a 2.9-fold increase in promoter activity
(Fig. 3). 59 deletion of ACCa sequences to 2391, 2136,
and 2108 bp had no effect on T0-901317 responsiveness.
Deletion of ACCa sequences containing the DR-4 element (2108 to 284 bp) abolished the stimulatory effect
of T0-901317 on ACCa transcription. Further deletion
to 241 bp had no effect on T0-901317 responsiveness.
Mutation of the SRE (280 to 271 bp) in the context of
108 bp of 59-flanking DNA caused a 49% reduction in
T0-901317 responsiveness. These results indicate that the
DR-4 element (LXRE) is required for T0-901317 regulation of ACCa transcription and that the SRE enhances the
ability of the LXRE to activate ACCa transcription in the
presence of T0-901317.
To determine whether the functional interaction between the ACCa LXRE and SRE required the presence
of additional cis-acting sequences, hepatocytes were transfected with constructs containing fragments of the ACCa
gene linked to the minimal promoter of the herpes simplex
virus thymidine kinase (TK) gene. The TK promoter alone
was unresponsive to T0-901317 (Fig. 4). When a DNA
fragment containing both the ACCa LXRE and the ACCa
SRE (2108 to 266 bp) was linked to the TK promoter,
treatment with T0-901317 caused a 5.5-fold increase in
promoter activity. Mutation of the ACCa SRE in the context
of the ACCa 2108 to 266 bp fragment caused a 49% decrease in T0-901317 responsiveness. When a DNA frag-

LXR activation increases the abundance of mature
SREBP-1 in chick embryo hepatocytes
In our studies analyzing the regulation of the ACCa
gene by T3, we showed that T3 treatment increased the
abundance of the mature, active form of SREBP-1 in chick
embryo hepatocytes and that this effect contributed to the
activation of ACCa transcription by T3 (8). This observation prompted us to ask whether T0-901317 regulated
SREBP-1 levels in chick embryo hepatocyte cultures. The
time course of the effects of T0-901317 on the abundance
of mature SREBP-1 protein, SREBP-1 mRNA, and ACCa
mRNA was determined in hepatocytes cultured in the
presence of insulin. Treatment with T0-901317 for 6 h
caused a 1.5-fold increase in mature SREBP-1 concentration (Fig. 5). A larger increase in mature SREBP-1 concentration (2.2-fold) was observed after 24 h of treatment
with T0-901317. In contrast to the time course for mature
SREBP-1, the T0-901317-induced stimulation of ACCa
mRNA levels occurred at a later time point (between
24 and 48 h of treatment). This observation is consistent
with the proposal that alterations in SREBP-1 levels play a
role in mediating the regulation of ACCa transcription by
T0-901317. Treatment with T0-901317 increased the abundance of SREBP-1 mRNA, and this effect was maximal
(1.9- to 2.1-fold) at or before 2 h of incubation. Thus, T0901317-induced changes in mature SREBP-1 concentration
appear to be mediated by a pretranslational mechanism.
Effect of LXR activation on histone acetylation of the
ACCa gene
The T0-901317-induced increase in ACCa transcription
may be mediated in whole or in part by alterations in
histone acetylation. Previous studies have shown that the
activation of LXR&RXR heterodimers by LXR ligands/
agonists triggers the recruitment of coactivator complexes
containing histone acetyltransferase activity (42, 43).
Increased histone acetylation causes a chromatin decondensation that enhances the accessibility of the basal
transcriptional machinery and other transcription factors
to the target promoter. To investigate the role of histone
acetylation in mediating the activation of ACCa transcription by T0-901317, ChIP experiments were performed in
chick embryo hepatocytes incubated in the absence or
presence of T0-901317. Hepatocytes were treated with 1%
formaldehyde to cross-link DNA to associated proteins.
Protein-DNA complexes were immunoprecipitated with
an antibody against acetylated histone H3 or an antibody
against acetylated histone H4. Immunoprecipitated DNA
Regulation of acetyl-CoA carboxylase by LXR
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Fig. 3. Effect of mutations of the 59-flanking region of ACCa promoter 2 on transcriptional activity in the
absence and presence of T0-901317. Chick embryo hepatocytes were transiently transfected with p[ACC2054/1274]chloramphenicol acetyltransferase (CAT) or equimolar amounts of other plasmids as described
in Experimental Procedures. After transfection, cells were treated with or without T0-901317 for 48 h. Cells
were then harvested, extracts were prepared, and CAT assays were performed. Left: The constructs used in
these experiments. The number at the left of each construct is the 59 end of the ACCa DNA in nucleotides
relative to the transcription initiation site of promoter 2. The 39 end of each construct was 1274 bp. The
locations of the liver X receptor response element (LXRE) (2101 to 286 bp) and the sterol-regulatory
element (SRE) (280 to 271 bp) are indicated by vertical lines. A block mutation of the SRE is indicated by
an X through the vertical line. Right: The CAT activity of cells transfected with p[ACC-108/1274]CAT and
treated with T0-901317 was set at 1, and the other activities were adjusted proportionally. The fold
stimulation by T0-901317 was calculated by dividing the CAT activity for hepatocytes treated with T0-901317
(1 T0-901317) by that for hepatocytes not treated with T0-901317 (2 T0-901317). The fold responses were
calculated for individual experiments and then averaged. The results are means 6 SEM of six experiments.
a
The fold stimulation by T0-901317 is significantly (P , 0.05) lower than that of p[ACC-108/1274]CAT;
b
the fold stimulation by T0-901317 is significantly (P , 0.05) lower than that of p[ACC-108/1274]CAT
containing a block mutation of the SRE.

was analyzed by PCR using primers that flanked the ACCa
LXRU. In hepatocytes incubated in the absence of T0901317, acetylation of histone H3 and histone H4 was
detected at the ACCa LXRU. Addition of T0-901317 to the
culture medium stimulated a rapid increase (<2 h) in the
acetylation of histone H3 and H4 (Fig. 6, Table 1). Histone
acetylation remained high for 6 h of T0-901317 treatment
and then declined between 6 and 24 h of T0-901317 treatment. These results support the proposal that an increase
in histone acetylation plays a role in mediating the effects
of T0-901317 on ACCa transcription.
We also used ChIP to assess the effects of T0-901317
treatment on histone acetylation in an uncharacterized
region of the SCD1 promoter using a primer set that amplified SCD1 sequences between 2369 and 2127 bp. In
contrast to the data for the ACCa gene, treatment with T0901317 had no effect on histone acetylation of this region
of the SCD1 gene (Fig. 6). This observation indicates that
the effects of T0-901317 on histone acetylation are
sequence-specific.

DISCUSSION
In previous work analyzing the effects of T3 on ACCa
transcription in avian hepatocytes, we identified a T3RE
2456
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that conferred T3 regulation on ACCa promoter 2 (7).
Interestingly, this T3RE not only bound protein complexes containing TR&RXR heterodimers but also bound
protein complexes containing LXR&RXR heterodimers. In
this report, we provide functional evidence that LXR&RXR
heterodimers regulate ACCa transcription. A specific
ligand/agonist of LXR (T0-901317) activates ACCa transcription, and this effect is mediated by the LXRE/T3RE
in ACCa promoter 2. We also demonstrate that SREBP-1 is
an accessory factor that enhances the ability of LXR&RXR
to increase ACCa transcription in the presence of T0901317 and that LXR activation by T0-901317 increases
the concentration of the mature, active form of SREBP-1
in chick embryo hepatocytes.
How does SREBP-1 enhance the stimulatory effects of
T0-901317 on ACCa transcription? One possibility is that
SREBP-1 facilitates the recruitment of coactivators to T0901317-bound LXR&RXR complexes. LXRa, LXRb, and
SREBP-1 interact with several coactivator proteins, including
CREB binding protein (CBP) and the TRAP/ARC/DRIP
complex (42–47). We postulate that the presence of SREBP1 on ACCa promoter 2 provides additional coactivator interaction sites that stabilize the binding of CBP, TRAP/
ARC/DRIP, and other coactivators to T0-901317-bound
LXR&RXR. In support of this model, SREBP-1 and nuclear
hormone receptors interact with separate peptide se-

Fig. 4. The ACCa SRE alone enhances the transcriptional activity of the ACCa LXRE in the presence of
T0-901317. Fragments of the ACCa gene containing the LXRE and/or SRE were linked to the minimal
thymidine kinase (TK) promoter in TKCAT. Chick embryo hepatocytes were transiently transfected with
these constructs and treated with or without T0-901317 as described in the legend to Fig. 3 and in
Experimental Procedures. Left: The constructs used in these experiments. Numbers indicate the 59 and 39
boundaries of the ACCa DNA relative to the transcription initiation site of promoter 2. A block mutation of
the SRE is indicated by an X across the box representing the SRE. Right: The CAT activity in hepatocytes
transfected with TKCAT and treated without T0-901317 was set at 1, and the other activities were adjusted
proportionally. The fold stimulation by T0-901317 was calculated as described in the legend to Fig. 3. The
results are means 6 SEM of five experiments. a The fold stimulation by T0-901317 for p[ACC-108/-66]
TKCAT is significantly (P , 0.05) higher than that of any other construct.

quences on CBP and separate subunits of the TRAP/ARC/
DRIP complex (48–51).
SREBP-1 also enhances the ability of TR&RXR to activate
ACCa transcription in the presence of T3 (9). In analyzing
the mechanism mediating this effect, we showed that
SREBP-1 interacted physically with TR and that binding of
T3 to TR enhanced this interaction. We postulated that
SREBP-1&SREBP-1 homodimers formed a tetrameric complex with TR&RXR heterodimers and that tetrameric
complex formation enhanced the recruitment of coactivators to ACCa promoter 2. We also showed in these
studies that LXR&RXR heterodimers do not interact
physically with SREBP-1. Thus, in contrast to the mechanism by which SREBP-1 enhances TR&RXR activity, direct
interactions between SREBP-1 and LXR&RXR do not play a
role in mediating the stimulatory effects of SREBP-1 on
LXR&RXR activity.
The mechanism by which LXR agonists regulate transcription has been analyzed for other lipogenic genes.
In human hepatoma cells, T0-901317 activation of FAS
transcription is mediated by a single LXRE in the FAS
promoter (52). In primary rat hepatocyte cultures, the
T0-901317-induced increase in SREBP-1c transcription is
mediated by two LXREs in the SREBP-1c promoter (53, 54).
Both the FAS promoter and the SREBP-1c promoter contain one or more SREs that are located z110–540 bp downstream of the LXRE(s). In cells that express physiological
levels of LXR, these SREs enhance basal transcription but
have little or no effect on the regulation of transcription by
T0-901317. In contrast to these findings, the SRE in ACCa
promoter 2 enhances the T0-901317 regulation of transcription but has no effect on basal transcription in chick
embryo hepatocytes (Figs. 3, 4). These gene-specific differences in SRE activity may be attributable to variations in

the proximity of the SRE relative to the LXRE and other
cis-acting regulatory sequences. For example, the close association of the SRE with the LXRE/T3RE in ACCa promoter 2 may facilitate interactions between LXR&RXR and
SREBP-1 and the ability of SREBP-1 to enhance T0-901317
responsiveness, whereas the wide separation of the SREs
and LXREs in the FAS and SREBP-1c promoters may impede interactions between LXR&RXR and SREBP-1 and
the ability of SREBP-1 to enhance T0-901317 responsiveness. Previous studies have shown that the SREs in the FAS
and SREBP-1c promoters are closely linked to a binding
site for nuclear factor-Y (NF-Y) and that SREBP-1 activity is
dependent on interactions between SREBP-1 and NF-Y
(53–56). These interactions enhance the ability of SREBP1 to stimulate basal transcription. In contrast, the SRE in
ACCa promoter 2 is not closely associated with binding
sites for NF-Y. The lack of interaction of SREBP-1 with NF-Y
on ACCa promoter 2 may explain why the ACCa SRE is
not effective in modulating basal transcription.
Promoter 2 of the human ACCa gene and the rat ACCa
gene contains two closely spaced SREs that mediate the
effects of sterol depletion on ACCa transcription (57, 58).
In contrast to promoter 2 of the chicken ACCa gene, a
sequence resembling a DR-4 element is not present in the
region flanking the SREs in the human and rat ACCa
promoters. Thus, the role of SREBP-1 in mediating the
stimulatory effects of T0-901317 on ACCa transcription
may vary depending on the class of animals.
Another finding of this study is that LXR plays a permissive role in mediating the actions of insulin on ACCa
transcription in chick embryo hepatocytes. Insulin stimulates ACCa expression in the presence of T0-901317 but
has no effect on ACCa expression in the absence of
T0-901317 (Fig. 1). In rat hepatocytes, insulin enhances
Regulation of acetyl-CoA carboxylase by LXR
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Fig. 5. T0-901317 increases the concentration of mature
sterol-regulatory element binding protein-1 (SREBP-1)
in chick embryo hepatocyte cultures. Chick embryo
hepatocytes were isolated and incubated in serum-free
Waymouth’s medium containing insulin. At 18 h of incubation, the medium was changed to one of the same
composition. T0-901317 was added at this time. After 2, 6,
12, 24, and 48 h of T0-901317 treatment, cellular extracts
or total RNA were prepared as described in Experimental
Procedures. A: The abundance of mature SREBP-1 in
nuclear extracts was measured by Western analyses. The
abundance of SREBP-1 mRNA and ACCa mRNA was measured by Northern analysis. These data are from a representative experiment. B: Signals for mature SREBP-1
protein from Western analyses and SREBP-1 mRNA and
ACCa mRNA from Northern analyses were quantitated.
Levels of mature SREBP-1 protein, SREBP-1 mRNA, and
ACCa mRNA in hepatocytes treated with T0-901317 for 0 h
were set at 1. Values are means 6 SEM of four experiments. * The mean is significantly (P , 0.05) different
from that of cells incubated with T0-901317 for 0 h or without T0-901317 for 24 or 48 h.

the ability of T0-901317 to increase mature SREBP-1 concentration as a result of a stimulatory effect of insulin on
the processing of precursor SREBP-1 to mature SREBP-1
(59). We have confirmed this finding in chick embryo
hepatocytes (data not shown). Because SREBP-1 enhances
the LXR activation of ACCa transcription in chick embryo hepatocytes, we postulate that alterations in mature
SREBP-1 abundance mediate the stimulatory effects of insulin on ACCa transcription. In support of this hypothesis,
insulin does not increase the expression of ABCA1 in the
presence of T0-901317 (Fig. 1). Previous work has shown
that the ABCA1 gene is not a target of SREBP-1 (60).
Previous studies performed in rat hepatocytes indicate
that insulin induces ACCa expression by increasing the
activity of LXR. For example, Tobin et al. (61) have shown
that insulin stimulates a 10-fold increase in the expression
of LXRa mRNA and that ablation of the LXRa gene abolishes the stimulatory effect of insulin on ACCa expression.
Others have shown that insulin increases the transcription of SREBP-1c and that this effect is mediated by two
LXR&RXR binding sites in the SREBP-1c promoter (53, 54).
SREBP-1c is a key factor mediating the effects of insulin
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on ACCa transcription in rat hepatocytes (27, 62). These
findings contrast with our data indicating that LXR plays
a permissive role in mediating the effects of insulin on
ACCa transcription in chick embryo hepatocytes. The
reason for the differences between birds and rodents
in the mechanism by which insulin regulates ACCa transcription is not clear. They may reflect subtle classdependent differences in the role of insulin in the control
of lipogenesis and/or other metabolic processes in liver.
The ACCa LXRE/T3RE enhances ACCa transcription in both the absence and presence of T0-901317 and
T3, with a greater activation observed in the presence
of T0-901317 and T3 (Figs. 3, 4) (7). We previously hypothesized that the enhancer activity of the ACCa LXRE/
T3RE in the absence of T0-901317 and T3 was mediated
by LXR&RXR heterodimers, as the primary protein complexes that bind the ACCa LXRE/T3RE in the absence of
T0-901317 and T3 contain LXR&RXR heterodimers (7).
Recent studies have shown that the unliganded form of
LXR&RXR represses gene transcription as a result of its
ability to interact with corepressor proteins and that the
addition of LXR ligand increases gene transcription by

Fig. 6. Treatment of chick embryo hepatocyte cultures with T0-901317 causes a transient increase in
histone acetylation at the ACCa liver X receptor response unit (LXRU). Chick embryo hepatocytes were
isolated and incubated in serum-free Waymouth’s medium containing insulin. At 18 h of incubation, the
medium was changed to one of the same composition. T0-901317 was added at this time. After 2, 6, 24, and
48 h of T0-901317 treatment, the association of acetylated histone H3 (Ac-H3) and acetylated histone H4
(Ac-H4) with ACCa and SCD1 genomic sequences was measured. Chromatin immunoprecipitation assays
were performed as described in Experimental Procedures. Immunoprecipitates were analyzed by PCR using
primers that flanked the LXRU of ACCa promoter 2 and an uncharacterized region of the SCD1 promoter.
The regions of the ACCa and SCD1 genes that were amplified by PCR are indicated at top. Chromatin
samples that were processed in parallel without the application of primary antibody served as controls (No
Ab). The input lanes show the results of PCR using chromatin samples taken before the immunoprecipitation step. Results are representative of three independent experiments.

causing the release of corepressors and the recruitment of
coactivators to LXR&RXR (63). In view of these observations, we further hypothesize that LXR&RXR complexes
associated with the ACCa LXRE/T3RE in the absence of
T0-901317 and T3 are bound by endogenous LXR and/or
RXR ligands. Several lines of evidence support this
proposal. First, treatment of chick embryo hepatocytes
with naturally occurring agonists of LXR [22-(R)-hydroxy

TABLE 1. Effect of T0-901317 treatment on the acetylation of
histones at the acetyl-CoA carboxylase-a liver X receptor response unit
T0-901317 Treatment
Histone

Acetylated
histone H3
Acetylated
histone H4

0h

2h

6h
a

1.8 6 0.1

24 h
a

48 h

1.0

1.4 6 0.1

1.1 6 0.2 1.1 6 0.1

1.0

1.7 6 0.1a 2.2 6 0.2a 1.0 6 0.1 1.1 6 0.1

Signals from chromatin immunoprecipitation assays using the
indicated antibodies were quantitated. The data are expressed as fold
differences relative to samples from hepatocytes treated with T0-901317
for 0 h. Values are means 6 SEM of three experiments. Results from a
representative experiment are shown in Fig. 6.
a
Significantly different (P , 0.05) from cells treated with T0901317 for 0 h.

cholesterol] and RXR (9-cis retinoic acid) has little or no
effect on ACCa mRNA abundance (Fig. 1 and data not
shown). Second, the ACCa LXRE/T3RE is not associated
with the corepressor protein, nuclear receptor corepressor, in the absence of T0-901317 and T3 (41). Last, the
ACCa LXRE/T3RE is associated with acetylated histone
H3 and acetylated histone H4 in the absence of T0-901317
and T3 (Fig. 6). The ability of T0-901317 to increase the
transcriptional activity and histone acetylation of the
ACCa LXRE/T3RE is likely attributable to the fact that
this synthetic agonist is more effective than endogenous
LXR agonists in stimulating the recruitment of histone
acetyltransferase-containing coactivators to LXR&RXR
(42).
In summary, we show that T0-901317 activates ACCa
transcription by increasing the activity of LXR&RXR and
SREBP-1 and the acetylation of histone H3 and histone
H4 on ACCa promoter 2. The identification of small
molecules that selectively inhibit one or more of these
processes represents a potential strategy to enhance the
utility of T0-901317 in the treatment of atherosclerosis
and type 2 diabetes. The feasibility of this approach is
supported by recent studies demonstrating that suppression of ACCa expression reverses hepatic steatosis and
insulin resistance in rats fed a high-fat diet (64).
Regulation of acetyl-CoA carboxylase by LXR
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